Cover Image
市場調查報告書

脂肪肉瘤:全球臨床實驗檢討

Liposarcoma Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 297512
出版日期 內容資訊 英文 77 Pages
訂單完成後即時交付
價格
Back to Top
脂肪肉瘤:全球臨床實驗檢討 Liposarcoma Global Clinical Trials Review, H1, 2015
出版日期: 2015年02月18日 內容資訊: 英文 77 Pages
簡介

本報告提供脂肪肉瘤的治療藥相關臨床實驗調查分析,提供臨床實驗數及被實驗人數,Phase別及各方面狀況,有潛力的企業,正在開發的治療藥的資訊,臨床實驗簡介等,為您概述為以下內容。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中東·非洲的主要國家
    • 中·南美的主要國家

G7各國的臨床實驗:腫瘤科臨床實驗中脂肪肉瘤的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:階段別

E7各國的臨床實驗:腫瘤科臨床實驗中脂肪肉瘤的比例

E7各國的臨床實驗:Phase別

E7各國的臨床實驗:階段別

各方面的臨床實驗

Phase別臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對象

贊助商各類型臨床實驗

有潛力的贊助商

  • 參與脂肪肉瘤治療藥臨床實驗的主要企業

有前途藥物

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Pfizer Inc.
    • Johnson & Johnson
    • Zeltia, S.A.
    • Sanofi
    • Merck & Co., Inc.
    • F. Hoffmann-La Roche Ltd.
    • 第一三共
    • Cell Therapeutics, Inc.
    • Amgen Inc.
    • ACORN Research, LLC
  • 主要大學·研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • European Organization for Research and Treatment of Cancer
    • Fred Hutchinson Cancer Research Center
    • Memorial Sloan Kettering Cancer Center
    • Institut Bergonie
    • NCIC Clinical Trials Group
    • Medical University of South Carolina
    • Children's Oncology Group
    • University of Washington

主要的臨床簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2567CTIDB

GlobalData's clinical trial report, "Liposarcoma Global Clinical Trials Review, H1, 2015" provides data on the Liposarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liposarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Liposarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Liposarcoma
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Liposarcoma to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Liposarcoma to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Liposarcoma
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Liposarcoma Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Zeltia, S.A.
      • Clinical Trial Overview of Zeltia, S.A.
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • European Organization for Research and Treatment of Cancer
      • Clinical Trial Overview of European Organization for Research and Treatment of Cancer
      • Fred Hutchinson Cancer Research Center
      • Clinical Trial Overview of Fred Hutchinson Cancer Research Center
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • University of Heidelberg
      • Clinical Trial Overview of University of Heidelberg
      • Institut Bergonie
      • Clinical Trial Overview of Institut Bergonie
      • Grupo Espanol de Investigacion en Sarcomas
      • Clinical Trial Overview of Grupo Espanol de Investigacion en Sarcomas
      • Northwestern University
      • Clinical Trial Overview of Northwestern University
      • Children's Oncology Group
      • Clinical Trial Overview of Children's Oncology Group
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Liposarcoma Therapeutics, Global, Clinical Trials by Region, 2015*
  • Liposarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Liposarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Liposarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Liposarcoma Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Liposarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Liposarcoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Liposarcoma to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Liposarcoma to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Liposarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Liposarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Liposarcoma Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Liposarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Liposarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Liposarcoma Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Liposarcoma Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Liposarcoma Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Liposarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Liposarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Liposarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Liposarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Liposarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Zeltia, S.A., 2015*
  • Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015*
  • Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015*
  • Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015*
  • Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015*
  • Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015*
  • Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015*
  • Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2015*
  • Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015*
  • Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2015*
  • Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Bergonie, 2015*
  • Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Grupo Espanol de Investigacion en Sarcomas, 2015*
  • Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2015*
  • Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2015*

List of Figures

  • Liposarcoma Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Liposarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Liposarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Liposarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Liposarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Liposarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Liposarcoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Liposarcoma to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Liposarcoma to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Liposarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Liposarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Liposarcoma Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Liposarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Liposarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Liposarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Liposarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Liposarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Liposarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Liposarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top